Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million.

Quilting: The Lakes Area Quilt Guild will hold its regular monthly meeting on Thursday, March 27, 2025 in the meeting room of ...

MoonLake, a clinical-stage biopharma company developing immunology therapeutics, was created by an April 2022 merger with Helix Acquisition, a blank-check company formed by Cormorant. The hedge fund ...

It wouldn't be the first time Sigma had made such an update to one of its lenses: last year, it released the 24-70mm F2.8 DG DN II Art, which was 10% lighter than its predecessor. At 1090g (2.40lb), ...

Panasonic has rung the changes on this second edition of its full-frame flagship. The Lumix S1R II improves upon the original S1R in every key area, battery life excepted. For me, the most ...

BridgeBio Oncology has entered a definitive merger agreement with Helix Acquisition Corp II, which will result in the formation ... from a private investment in public equity (PIPE), led by Cormorant ...

When we asked which CP+ announcements you wanted us to take a closer look at, we got several responses asking for more information on the many third-party lenses that have been announced at the show.

Helix Acquisition Corp. II is now helping a biotech company go public. Helix (Nasdaq: HLXB) is a special purpose acquisition company based in Boston and formed by Cormorant Asset Management.

That financing will be led by Cormorant Asset Management and will see the likes of Novo Holdings, ADAR1 Capital Management, Omega Funds and BioCapital Advisors, to name a few, scooping up the stock.

The merger agreement announced Friday is with Helix Acquisition Corp. II, a SPAC sponsored by affiliates of Cormorant Asset Management. When the deal closes, the combined company will take the ...